Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilma Knol

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
British Journal of Clinical Pharmacology|August 22, 2018
Identification of behaviour change techniques in deprescribing interventions: a systematic review and meta-analysisChristina R Hansen, Denis O'Mahony, Patricia M Kearney, et al.
European Geriatric Medicine|August 20, 2024
The association between medication use and health-related quality of life in multimorbid older patients with polypharmacyCharlotte Falke, Fatma Karapinar, Marcel Bouvy, et al.
Drugs & Aging|May 23, 2023
Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM TrialFrançois-Xavier Sibille, Marie de Saint-Hubert, Séverine Henrard, et al.
European Geriatric Medicine|October 25, 2024
Correction: The association between medication use and health-related quality of life in multimorbid older patients with polypharmacyCharlotte Falke, Fatma Karapinar, Marcel Bouvy, et al.
Swiss Medical Weekly|April 10, 2026
Trends over time and risk factors in inappropriate prescribing in older adults with multimorbidity and polypharmacy: a longitudinal secondary analysis of the OPERAM trialJonathan Huschka, Katharina Tabea Jungo, Valerie Aponte Ribero, et al.
Journal of Clinical Medicine|October 16, 2025
Adherence to Guideline-Directed Medical Therapy in Hospitalized Older People with Heart Failure at Discharge and 3-Month Follow-UpRenee C M A Raijmann, Melanie Haverkamp, Manon G van der Meer, et al.
Journal of Clinical Psychopharmacology|April 24, 2013
Genetic variation and the risk of haloperidol-related parkinsonism in elderly patients: a candidate gene approachWilma Knol, Rob J van Marum, Paul A F Jansen, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Hyperpolypharmacy is a predictor of mortality after left ventricular assist device (LVAD) implantationLauren Dautzenberg, Lieke Numan, Wilma Knol, et al.
European Journal of Pharmacology|January 11, 2025
Students' perspective on the Dutch National Pharmacotherapy Assessment, a national survey study among final-year medical studentsErik M Donker, Floor van Rosse, Ben J A Janssen, et al.
European Geriatric Medicine|June 16, 2023
Correction: STOPP/START criteria for potentially inappropriate prescribing in older people: version 3Denis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
British Journal of Clinical Pharmacology|August 22, 2018
Identification of behaviour change techniques in deprescribing interventions: a systematic review and meta-analysisChristina R Hansen, Denis O'Mahony, Patricia M Kearney, et al.
European Geriatric Medicine|August 20, 2024
The association between medication use and health-related quality of life in multimorbid older patients with polypharmacyCharlotte Falke, Fatma Karapinar, Marcel Bouvy, et al.
Drugs & Aging|May 23, 2023
Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM TrialFrançois-Xavier Sibille, Marie de Saint-Hubert, Séverine Henrard, et al.
European Geriatric Medicine|October 25, 2024
Correction: The association between medication use and health-related quality of life in multimorbid older patients with polypharmacyCharlotte Falke, Fatma Karapinar, Marcel Bouvy, et al.
Swiss Medical Weekly|April 10, 2026
Trends over time and risk factors in inappropriate prescribing in older adults with multimorbidity and polypharmacy: a longitudinal secondary analysis of the OPERAM trialJonathan Huschka, Katharina Tabea Jungo, Valerie Aponte Ribero, et al.
Journal of Clinical Medicine|October 16, 2025
Adherence to Guideline-Directed Medical Therapy in Hospitalized Older People with Heart Failure at Discharge and 3-Month Follow-UpRenee C M A Raijmann, Melanie Haverkamp, Manon G van der Meer, et al.
Journal of Clinical Psychopharmacology|April 24, 2013
Genetic variation and the risk of haloperidol-related parkinsonism in elderly patients: a candidate gene approachWilma Knol, Rob J van Marum, Paul A F Jansen, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Hyperpolypharmacy is a predictor of mortality after left ventricular assist device (LVAD) implantationLauren Dautzenberg, Lieke Numan, Wilma Knol, et al.
European Journal of Pharmacology|January 11, 2025
Students' perspective on the Dutch National Pharmacotherapy Assessment, a national survey study among final-year medical studentsErik M Donker, Floor van Rosse, Ben J A Janssen, et al.
European Geriatric Medicine|June 16, 2023
Correction: STOPP/START criteria for potentially inappropriate prescribing in older people: version 3Denis O'Mahony, Antonio Cherubini, Anna Renom Guiteras, et al.
Pageof 10